Abstract
MR-guided focused ultrasound (MRgFUS) has proven its efficacy and safety for the treatment of essential tremor (ET) and/or Parkinson’s disease (PD). However, having a cardiac pacemaker has been considered an exclusion criterion for the use of MRgFUS. Only 2 patients with a cardiac pacemaker treated with MRgFUS have been previously reported, both treated using 1.5-T MRI. In this paper, the authors present their experience performing 3-T MRgFUS thalamotomy in 4 patients with an implanted cardiac pacemaker. Treatments were uneventful regarding complications or severe side effects. MRgFUS using 3-T MRI was found to be an efficient and safe treatment for ET and/or PD in patients with an MRI-compatible pacemaker. https://thejns.org/doi/abs/10.3171/2024.6.FOCUS24171
Author supplied keywords
Cite
CITATION STYLE
Gonzalez-Quarante, L. H., Gonzalez-Crespo, A., Arcadi, A., Macias-de-la-Corte, M., Aviles-Olmos, I., Sanchez-Catasus, C. A., … Guridi, J. (2024). 3-T MR-guided focused ultrasound thalamotomy for tremor in patients with a cardiac pacemaker: case series and review of the literature. Neurosurgical Focus , 57(3). https://doi.org/10.3171/2024.6.FOCUS24171
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.